18175 Refining the Management of CMV in HCT Recipients: What Does the Future Hold?
In this activity, based on a recent symposium held at the 2018 BMT Tandem Meetings, experts discuss the clinical trends of cytomegalovirus (CMV) infection post-hematopoietic cell transplant (HCT) and map out the future of CMV management by analyzing the latest clinical evidence on novel approaches for prevention and treatment.
This activity has been designed to meet the educational needs of hematologist-oncologists, oncologists, BMT specialists and BMT nurse specialists, and other clinicians involved in the care of patients undergoing HCT.
- Discuss unmet needs associated with the management of CMV infection in HCT recipients
- Assess recent efficacy and safety data regarding novel approaches to prevent and treat CMV infection in the HCT setting
- Integrate expert recommendations and the results of recent clinical studies into strategies to prevent and treat CMV infection after HCT
Francisco M. Marty, MD
Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Kathleen Mullane, DO, PharmD, FIDSA
Professor, Department of Medicine
Section of Infectious Diseases
Director of Infectious Disease Clinical Trials
Immunocompromised Host Service
University of Chicago
All persons in control of content have no relevant financial relationships to disclose.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and PeerView Institute for Medical Education. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.